Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

Hemant Surgical Industries Limited IPO Review

Hemant Surgical Industries Limited IPO was engaged in the business of manufacturing, assembling, importing, and the company markets a portfolio of medical equipment and disposable. Their products are manufactured under controlled conditions and a suitable working environment is provided. They face competition from organized and unorganized players in the healthcare industry which have a presence in multiple regions in India. 

Their strategies are focused on consistently meeting quality standards, Deepan, expanding their geographical presence, capitalizing on industry tailwinds, and focusing on backward integration. Their Aim is to keep their cost of production low to maintain their competitive advantages and their profit margins. 

Hemant Surgical Industries Limited Products and Services

Hemant Surgical Industries products are they are offering a wide spectrum of equipment and disposables required for Renal Care, cardiovascular disease, Critical Care and Radiology, and Surgical disposables. Their Company started its operations by importing and marketing medical disposables like meditates, all over India from JMS Co Ltd. Hemant surgical company’s strengths are they offer a diversified range of products, Quality assurance, an existing well-established reputation, and customer relationships, an Experienced management team with industry, Stable financial performance with improved margins. Hemant surgical industries ltd. products are Respiratory Disease Related Medical equipment, Critical Care and Radiology Medical equipment, Surgical Disposables, and Other Healthcare Products. 

Financial Overview

The Company is in the business of medical equipment and is engaged in manufacturing and marketing, they regularly update their existing facilities and technologies. Its reported growth in its top and bottom lines in recent years. Based on financial statements issue is reasonably priced. Investors may apply for this IPO for medium to long-term rewards.